Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 367 results found. Search for [ Dr Reddy's Laboratories ]

Results 1 to 21 of 367
BusinessToday.In
November 20, 2019
Market witnessed bullishness in the initial trading session mainly on the back of favourable cues on the domestic front.


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


E Kumar Sharma
New Delhi, November 2, 2019
Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes


BusinessToday.In
New Delhi, November 1, 2019
Dr. Reddy's Lab Q2 results: Consolidated revenue during July-September quarter of this fiscal rose by 26.41 per cent to Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period


BusinessToday.In
New Delhi, October 30, 2019
Sixteen CEOs and economists lay out a roadmap to revive the economy


Joe C Mathew
New Delhi, October 30, 2019
The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


Reuters
New Delhi, September 27, 2019
The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


PTI
September 2, 2019



Reuters
August 8, 2019
Huawei, the world's biggest maker of such gear, is at the centre of a geopolitical tug-of-war between China and the United States


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PTI
June 20, 2019



E Kumar Sharma
New Delhi, June 10, 2019
Drug regulatory reforms in China have turned the heat on the Indian pharmaceutical industry and raised the cost of bulk drugs. But some firms have managed to turn the crisis into an opportunity by filling in the space left by the Chinese.


BusinessToday.In
June 4, 2019
Share Market Live: While Sensex fell 184 points to 40,083 with 15 components in the red, Nifty lost 66 points to 12,021.


PTI
June 3, 2019



E Kumar Sharma
May 18, 2019
The Hyderabad-headquartered firm posted a 4 per cent sequential and 14 per cent year-on-year (YoY) growth in revenues at Rs 4,017 crore in Q4FY19


PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


PTI
May 15, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


PAGES 1 OF 19  12345